Kinnate Biopharma Inc

Kinnate Biopharma Inc Stock

—P/E
€116.22MMarket capitalisation
-US$2.78Earnings
—Dividend yield

Current price

—
1D
1W
1M
3M
6M
1Y
3Y
Max

Company description

Kinnate Biopharma Inc is a clinical-stage precision oncology company focused on the discovery, design, and development of small molecule kinase inhibitors for difficult-to-treat, genomically defined cancers. The company's pipeline product candidates are; exarafenib (KIN-2787), which is a Rapidly Accelerated Fibrosarcoma (RAF) inhibitor in development for the treatment of patients with lung cancer, melanoma, and other solid tumors, and KIN-3248, a Fibroblast Growth Factor Receptors (FGFR) inhibitor, designed for the treatment of patients with intrahepatic cholangiocarcinoma (ICC), a cancer of the bile ducts in the liver, and urothelial carcinoma (UC), a cancer of the bladder lining, as well as other solid tumors.

Kinnate Biopharma Inc is registered in the following country: United States of America (Exchange: USNASD).

Key metrics

Key metrics and master data for the Kinnate Biopharma Inc stock.

Market capitalisation
€116.22M
P/E
—
P/B
0.78
P/S
—
P/CF
-1.23
Issued shares 47M Units

Return

Here you can see the performance of the Kinnate Biopharma Inc stock.

PeriodPerfor­mance
1 Week+0.83 %
1 Month+7.96 %
3 Months+11.93 %
6 Months+89.15 %
1 Year-56.81 %
YTD+11.93 %

Dividends

With an (expected) annual dividend of —, the current stock price results in a dividend yield of —.

Dividend type—
(Expected) annual dividend —
Dividend yield —

Splits

The table shows the splits of the Kinnate Biopharma Inc share.

DateRatio
No data available.

Which ETF contains the Kinnate Biopharma Inc stock?

The Kinnate Biopharma Inc stock is contained in a total of 0 ETFs with at least 1%. You can find a list of these ETFs in the following table. With —, Kinnate Biopharma Inc has the largest weight in .

Name
Weighting
Region
Country
TER
Replication
Volume (£m)

Frequently asked questions

Here you can find all answers to your questions about the Kinnate Biopharma Inc stock.

Master data is provided by Morningstar (stocks, ETFs, funds), CoinGecko (cryptocurrencies) and Isarvest GmbH. Price data is at least 15-minute delayed exchange prices (stocks, ETFs, funds) or NAV prices (ETFs, funds). Real-time prices – where available – are provided by the providers and Lang & Schwarz (stocks, ETFs, funds) and CoinGecko (cryptocurrencies).

Isarvest GmbH assumes no liability for the information presented and cannot guarantee that the data is complete and accurate.

Affiliate notice *
Links marked with an asterisk (*) are advertising or affiliate links. If you purchase or sign up through this link, we receive compensation from the provider. This comes at no additional cost or disadvantage to you. We use this revenue to fund our free services. Thank you for your support.